Cochrane Abstracts
Non‐pharmaceutical management of respiratory morbidity in children with severe global developmental delay
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Non‐pharmaceutical Management of Respiratory Morbidity in Children With Severe Global Developmental Delay." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431082/all/Non‐pharmaceutical_management_of_respiratory_morbidity_in_children_with_severe_global_developmental_delay.
Non‐pharmaceutical management of respiratory morbidity in children with severe global developmental delay. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431082/all/Non‐pharmaceutical_management_of_respiratory_morbidity_in_children_with_severe_global_developmental_delay. Accessed January 25, 2025.
Non‐pharmaceutical management of respiratory morbidity in children with severe global developmental delay. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431082/all/Non‐pharmaceutical_management_of_respiratory_morbidity_in_children_with_severe_global_developmental_delay
Non‐pharmaceutical Management of Respiratory Morbidity in Children With Severe Global Developmental Delay [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431082/all/Non‐pharmaceutical_management_of_respiratory_morbidity_in_children_with_severe_global_developmental_delay.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Non‐pharmaceutical management of respiratory morbidity in children with severe global developmental delay
ID - 431082
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431082/all/Non‐pharmaceutical_management_of_respiratory_morbidity_in_children_with_severe_global_developmental_delay
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
